Executive Vice President, Chief Commercial Officer
Mr. Kody joined Horizon Pharma as executive vice president, chief commercial officer in November 2014. He has more than 20 years of executive, general management and commercial experience in the diagnostics, pharmaceutical, biotechnology and medical device industries.
Mr. Kody was most recently president, Leica Biosystems Richmond Inc., a subsidiary of Danaher Corporation (NYSE: DHR), focused on advancing cancer diagnostics to improve lives. His role included full P&L responsibility and the leadership and integration of multiple global acquisitions in the United States and Europe.
Before joining Leica in 2010, Mr. Kody held various vice president level positions at Baxter Healthcare Corporation, including a key role as vice president of innovative therapies, which focused on the commercialization of therapies that change clinical practice. Other responsibilities included management of global marketing, health economics, business strategy and acquisition integration.
Before joining Baxter in 2006, Mr. Kody was with Abbott, first as a business unit director and then as sales director, leading Abbott’s first $1 billion pharmaceutical brand, Depakote®. Previous to Abbott, he was director of strategy for the $5 billion neuroscience division at Eli Lilly and Company, which included Prozac® and Zyprexa®. Earlier in his career, he was employed with Hill-Rom Holdings, Inc. and Ford Motor Company.
Mr. Kody received a bachelor’s degree in mechanical engineering from the University of Michigan and an MBA from the University of Michigan’s Ross School of Business.